Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 553.40 1.56
Hindalco 191.60 0.52
Tata Pow 97.95 1.66
Coal Ind 368.95 0.49
Ntpc Ltd 145.00 3.01
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Wanbury Limited
Wanbury Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:524212NSE:WANBURYBloomberg:WANB@INReuters:WANB.BO
Market Lot: 1Face Value: 10ISIN Demat: INE107F01022
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
26-SEP-13 Wanbury announced that the company's manufacturing facilities at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, 05-AUG-13 Wanbury announced that corporate debt restructuring (CDR) approved by the bankers of the company and approval of the shareholders through postal ballot resolution. 13-AUG-10 Pharmaceutical company, Wanbur...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Wanbury jumps 20% as USFDA clears two facilities as acceptable  -IRIS 27-Sep-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2014(12)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 4193.814114.983416.47
Other Income54.6045.49108.24
Total Income4248.414160.473524.71
Cost of goods sold3911.523981.673348.26
OPBDIT336.89178.80176.45
PAT-98.09-254.69-161.37
Gross Block---
Equity capital199.69173.79173.79
EPS (Rs.)--14.65-10.97
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI) 7.9 4.3 5.0
Net margin (% of OI)-2.3-6.1-4.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
BSEL Tech Park, B - Wing
10th Floor, Sector 30 - A
Opposite Vashi Railway Station
Vashi
Navi Mumbai
Maharashtra-400 705
PHONE
(022) 6794 2222
FAX
(022) 6794 2111/ 333
 
Board of Directors
Board Meetings
Date Purpose
07-AUG-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer